This year’s Dickson Prize in Medicine will be given by the University of Pittsburgh School of Medicine to a Massachusetts Institute of Technology biologist who discovered a signaling network that controls cell growth and has since found basic mechanisms related to the network in human biology and human disease.
David M. Sabatini is also a senior associate member of the Broad Institute of MIT and Harvard University. He will receive the prize at the Science 2017 showcase held Oct. 18-20 at Pitt.
“Dr. Sabatini is an extraordinarily innovative and imaginative scientist,” said Arthur S. Levine, PItt’s senior vice chancellor for the health sciences and dean of medicine, in a July 14 news release on the Dickson Prize.
Dr. Sabatini’s discoveries of the regulatory metabolic pathway known as mTOR (short for mechanistic target of rapamycin) came when he was a medical student researcher. Since then, work in his lab has “led to the identification of many components of the pathway and to an understanding of their cellular and organismal functions,” the Pitt announcement said.
The Sabatini lab now focuses on the role of metabolism in cancer and new technologies that help in the analysis of gene function in mammalian cells. In 2002, Dr. Sabatini became a member of the Whitehead Institute for Biomedical Research in Cambridge, Mass., and joined the MIT faculty. In 2015, he was elected to the National Academy of Sciences.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.